News

Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...
Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...
Sandoz sues Amgen in U.S. court over Enbrel patents, alleging efforts to block biosimilar Erelzi and delay competition in the ...
By Oliver Hirt ZURICH (Reuters) -Swiss generic drug manufacturer Sandoz said on Monday it had filed an antitrust lawsuit in ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing RulesCompany aims to accelerate access to much-needed biosimilar to reference ...
Swiss generic and biosimilar medicines firm Sandoz (SIX: SDZ) today announced it has filed an antitrust lawsuit in the USA ...
An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.
She started treatment with etanercept (Enbrel ®) 1 month previously. One day after a subcutaneous injection into the left thigh, she developed a mildly pruritic eruption on the right thigh ...
Generic drugmaker Sandoz (OTCQX:SDZXF) announced on Monday the filing of an antitrust lawsuit alleging that Amgen ...
Sandoz (SDZNY) announced the filing of an antitrust lawsuit in the U.S. against Amgen (AMGN), for extending and entrenching the dominant market ...
A federal judge on Friday dismissed a lawsuit that challenged Colorado's power to cap prescription drug costs.
Sandoz has filed an antitrust lawsuit in the United States against Amgen, for extending and entrenching the dominant market ...